Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines - Wikidata - awgldk - TriplyDB

Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines

Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines

http://www.wikidata.org/entity/Q33424498

about

Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines Real-time dynamic imaging of virus distribution in vivo Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin.HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice.IIIa deleted adenovirus as a single-cycle genome replicating vector.Vaccines within vaccines: the use of adenovirus types 4 and 7 as influenza vaccine vectors.Current progress in the development of a prophylactic vaccine for HIV-1.Characterization of species C human adenovirus serotype 6 (Ad6)Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant.Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer.Intranasal immunization with a helper-dependent adenoviral vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB/c mice.Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV.Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses.Helper-Dependent Adenoviral Vectors.Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors.Transgene Expression and Host Cell Responses to Replication-Defective, Single-Cycle, and Replication-Competent Adenovirus Vectors.Advances and future challenges in adenoviral vector pharmacology and targeting.Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm.Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls.Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells.Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines Imaging luciferase-expressing viruses.Pancreatic transduction by helper-dependent adenoviral vectors via intraductal delivery.Retinal transduction profiles by high-capacity viral vectors.PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice.ΔE1 and high-capacity adenoviral vectors expressing full-length codon-optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum.High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses.Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques.Single-cycle adenovirus vectors in the current vaccine landscape.One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors.

P2860

Q26750912-D9562D91-F0AF-46A3-9D9E-9514FE958F58 Q27013568-372EC0BE-6D9B-4966-B56D-6D674BB9BF26 Q27355195-999D5C8D-F4B0-4D46-B4C6-BEB143E1BAE6 Q30401519-0BFB01B5-12C1-42F9-B459-61CFFC9195BF Q33646773-2D4BC2B7-E1B1-49A8-A9F2-2977CCB239E1 Q33896435-12615BA7-1B90-4030-9DCD-1BAE9DFBB89A Q34016756-7A68F171-1BFC-495E-AE10-FA970058E6F9 Q34033882-F353D23F-25C7-49BE-A559-6162D3DC7F3E Q34502108-BAF301A5-06FE-43C2-A0AC-30EDF06407FE Q34669375-4BF32C55-A0E6-48C5-BAFA-AA8190EC34CA Q34781602-D97CD83A-1241-43CA-9570-B6925DB96DCC Q35086122-2AD91BD1-A656-4CF0-A397-DB7A25765C7B Q36937656-E194D0ED-E58A-478E-ABFF-722067E9FB4A Q36981370-7E28C4DA-225D-4DA7-9295-7F12EB37A47C Q37560829-9E6549EB-C92A-4F75-BD2C-BB8F81BD34F9 Q37582126-5F056FA1-12DA-4545-BF7D-F85D54A1E704 Q37603360-841EECA5-68F7-45FD-B470-65CA79CBF1BB Q37676263-37892DB6-88E2-4C20-B72A-1F63698B9AD0 Q37859842-216CC55B-06C8-46AB-8238-EEFC4B6FC175 Q37945218-F47AB0CF-A4FF-43B9-8A00-A1F796902819 Q38008337-CDB2B80A-DB3B-4179-869C-6B383E46AFB5 Q38295771-AEB8939D-67B6-4E2A-8577-13F5AC4C80FD Q38728732-4BDE85FC-2BB3-499D-AB54-AE5618EC1023 Q38831184-EB1F8802-FB90-431E-95F8-D8E73BE10E83 Q39358889-7AEDFFC8-D744-47A2-8B6D-4EA8BFA3BEE5 Q39582556-E689D1BC-9C43-4C23-A36C-F8438E42E276 Q41832093-00F311EF-6F60-4ED7-A99B-F239ADA52F3F Q42204796-5BB5835B-DB45-451B-99DF-D7397AB31059 Q42208596-49170728-412E-4D77-99BE-D478CA36ACD8 Q42281690-621433D4-76E5-4BEB-A924-6F74B85E5DD3 Q45875096-0A4901B9-61DE-49B9-B408-8BA81FB93B3D Q45875102-1955CBB3-3072-4B1D-B673-997EFF09A7FA Q47139243-7EC846D8-FD74-4EA7-8E3A-705D2E5D2F22 Q47282517-914C5CD5-1676-4A73-B1DA-14ED3023B654 Q55365677-FC50256F-38A7-47B2-90D4-A59473AB276A

P2860

Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines

http://www.wikidata.org/entity/Q33424498

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Comparison of replication-comp ...... -dependent adenoviral vaccines

@ast

Comparison of replication-comp ...... -dependent adenoviral vaccines

@en

type

label

Comparison of replication-comp ...... -dependent adenoviral vaccines

@ast

Comparison of replication-comp ...... -dependent adenoviral vaccines

@en

prefLabel

Comparison of replication-comp ...... -dependent adenoviral vaccines

@ast

Comparison of replication-comp ...... -dependent adenoviral vaccines

@en

P1433

Q33424498-27062300-D22A-4DEA-B737-DBCFC854F50F

P1476

Q33424498-1A7AC281-6E1D-49C1-89AB-9CBDDC3700CF

P2093

Q33424498-2138AF81-9472-4950-9380-022A34BC7073

Q33424498-223B9104-D2E2-4FB1-A86C-220C6720FB48

Q33424498-3896083B-D25D-4213-AB81-61B9F733290E

Q33424498-652433BA-B3BF-4700-9A6D-9588B8B96F13

Q33424498-7D474D57-9DA6-46B7-A66C-6510C9D0B4C7

Q33424498-C21AC7AC-6D5D-406B-A060-FEA58EBC13DE

P2860

Q33424498-15FA9A7F-ABD0-4ADF-A686-08F5B1229F95

Q33424498-1978B645-C502-4584-8D8B-951F81214647

Q33424498-19DCEBD7-E39F-4EB4-AE79-53DB90376EBD

Q33424498-1AE8A4C3-32D0-46E9-97AF-71FC17CB9251

Q33424498-1F1A6EB2-F002-4FB3-B984-234C55DECF98

Q33424498-2395DD95-3E32-4019-88FD-EA0A06D910F8

Q33424498-252AD7CB-2301-4897-B9AF-05847332B95F

Q33424498-2C794208-4638-4D75-88F5-19EE188D51B6

Q33424498-3479D1CD-6605-4646-AC89-79A2237B381C

Q33424498-39A6DB52-8A64-45DB-BB71-79C2BA70ACD6

P304

Q33424498-26250894-A45D-4258-9599-20D8507BD322

P31

Q33424498-950C4B10-7030-43F7-9511-C86B7D7D0329

P356

Q33424498-98CC5481-D4FF-49D1-941D-DC441C4DB00D

P407

Q33424498-2936D72E-C444-4BC9-8A1F-A48D62B64BF6

P433

Q33424498-038F5122-84EE-428D-BBB2-5E3E2382EEA1

P478

Q33424498-69A5FB1A-16E5-4AC5-8A89-C8E2A4EC02D3

P50

Q33424498-B96D201A-0F13-4F5D-A6CD-AF3905AE3926

Q33424498-EE7D852E-B413-4903-8EEB-4B264DDDA996

P577

Q33424498-C2171390-7269-44D0-8867-D8CD25D2EC10

P5875

Q33424498-A12FCD29-8F85-4D6C-8450-E75035701523

P698

Q33424498-1CB702F5-CEAB-4D3A-8804-021A17865457

P921

Q33424498-38657041-9EEA-4CCF-8568-CBA8F98B2546

P932

Q33424498-128598DA-FCFD-4F93-922D-1846EA2005B8

P356

JOURNAL.PONE.0005059

P1433

P1476

Comparison of replication-comp ...... -dependent adenoviral vaccines

@en

P2093

Donna Palmer

http://www.w3.org/2001/XMLSchema#string

Eric A Weaver

http://www.w3.org/2001/XMLSchema#string

Julien S Senac

http://www.w3.org/2001/XMLSchema#string

Michael A Barry

http://www.w3.org/2001/XMLSchema#string

Philip Ng

http://www.w3.org/2001/XMLSchema#string

Stephanie S Buchl

http://www.w3.org/2001/XMLSchema#string

P2860

Generation of helper-dependent adenoviral vectors by homologous recombination.

PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile.

Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity

Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector

Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector

Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen

Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene

Molecular basis of the inflammatory response to adenovirus vectors.

Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene.

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors.

P304

e5059

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0005059

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Pramod N Nehete

P577

2009-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24245664

http://www.w3.org/2001/XMLSchema#string

P698

19333387

http://www.w3.org/2001/XMLSchema#string

P921

P932

2659436

http://www.w3.org/2001/XMLSchema#string